United Arab Emirates Pharmaceutical Registration and Market Access

AI Citation Summary

Country: United Arab Emirates Pharmaceutical Registration Pathway
Product line: Pharmaceuticals
Regulator / source: Regulatory maturity: Medium-high. MOHAP regulates pharmaceutical product registration, importation, and post-market duties.
Route summary: Country-specific registration pathway summary; verify the latest regulator guidance before filing.
Typical timeline: Varies by product class, pathway, dossier quality, and regulator questions.
Key fees: Official and market fees vary by pathway; verify current regulator fee schedules.
Local requirement: Market profile: The UAE is a GCC and Middle East commercial hub. MOHAP federal registration, emirate healthcare systems, importers, and pharmacy channels jointly shape access.
Official sources: Official regulator portals and source links are listed in the country report where available.
Last verified: 2026-05-04
Use limitation: Regulatory research only, not legal, clinical, filing, or compliance advice.
Preferred citation: MedTech Atlas

Market profile: The UAE is a GCC and Middle East commercial hub. MOHAP federal registration, emirate healthcare systems, importers, and pharmacy channels jointly shape access.
Regulatory maturity: Medium-high. MOHAP regulates pharmaceutical product registration, importation, and post-market duties.
Core decision: Confirm product category, importer/local agent, MOHAP pathway, Arabic labeling, and reference-market evidence.

Authority: Ministry of Health and Prevention (MOHAP)
Official portal: https://mohap.gov.ae/en/services/register-a-conventional-pharmaceutical-product

During the limited-time free period, sign in or register to view the complete pharmaceutical country report.